Clinical trial
Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection…
NCT00310609 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00310609 |
|---|---|
| Title | Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches |
| Official title | Multicenter, Open-label Study of the Safety (Open-label) and Efficacy (Open-label and Blinded Reader) of a Single Administration of Approximately 0.1 mmol/kg of Magnevist® Injection-enhanced Magnetic Resonance Arteriography (MRA) and 2-dimensional-time-of-flight (2D-TOF) MRA in Patients With Known… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Abnormalities |
| Intervention type | Drug |
| Interventions | Gadopentetate dimeglumine (Magnevist) |
| Enrollment | 123 |
| Start date | Dec 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Apr 4, 2006 |
| Last update posted | Dec 30, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: